Deferration using anguibactin siderophore

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31295

Patent

active

053937775

ABSTRACT:
Methods for removing ferric iron from aqueous liquids and for performing deferration therapy are disclosed, involving the use of a novel siderophore, termed anguibactin. Anguibactin is isolated from a marine pathogen, Vibrio anguillarum, containing the pMJ1 plasmid. Anguibactin inhibits iron uptake by living cells, wrests iron from vertebrate tissues, removes iron from other siderophores and ferric hydroxide, and removes ferric iron from aqueous solutions, including cell-culture media. For deferration therapy, anguibactin from which bound iron has been removed is administered by dissolving in water or other liquid aqueous pharmaceutical carrier at a dosage typical for other siderophores. Anguibactin is preferably administered intramuscularly or subcutaneously, but can be given intravenously. Oral administration is also possible, particularly if the siderophore is encapsulated in a form allowing it to pass intact through the acidic environment of the stomach but become available for absorption in the intestine. This siderophore has the advantages of low molecular weight, extremely high affinity for ferric iron, and non-use by any known human pathogen. The structure is amenable to immobilization on a solid substrate.

REFERENCES:
patent: 3118823 (1964-01-01), Gaeumann et al.
patent: 3153621 (1964-10-01), Gaeumann et al.
patent: 4530963 (1985-07-01), DeVoe et al.
patent: 4585559 (1986-04-01), DeVoe et al.
patent: 4666927 (1987-05-01), Hider et al.
Chemical Abstracts (105: 130412h) 1986.
Chemical Abstracts (109: 67801z) 1988.
Tolmasky, et al., "Increased Production of the Siderophore Anguibactin Mediated by pJM1-Like Plasmids in Vibrio anguillarum," Infection and Immunity 56:1608-1614 (Jun., 1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Deferration using anguibactin siderophore does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deferration using anguibactin siderophore, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deferration using anguibactin siderophore will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-848741

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.